These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5333600)

  • 1. [Dependence of antagonistic properties of coli bacteria on the level of their sensitivity to levomycetin].
    Botvinik SA; Gurkova EA
    Antibiotiki; 1965 Oct; 10(10):900-4. PubMed ID: 5333600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the mechanisms of levomycetin inactivation by the palgue causative agent and Escherichia coli with episomal and chromosomal resistance. The enzymatic acetylation of levomycetin].
    Korobeĭnik NV; Lebedeva SA; Mishan'kin BN; Abramova LA; Domaradskiĭ IV
    Antibiotiki; 1975 Sep; (9):817-23. PubMed ID: 1101811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of chloramphenicol resistance in naturally occurring chloramphenicol resistant bacteria.
    Okamoto S; Suzuki Y
    Jpn J Med Sci Biol; 1968 Jun; 21(3):220-1. PubMed ID: 4881255
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of conjugation in bacteria. I. Effect of chloramphenicol on conjugation in Escherichia coli K-12.
    Friszke E
    Acta Microbiol Pol A; 1970; 2(3):123-31. PubMed ID: 4922313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chloramphenicol resistance of different strains of Escherichia coli. Acetylation of the antibiotic].
    Piffaretti JC; Pitton JS
    Pathol Microbiol (Basel); 1969; 34(3):151-2. PubMed ID: 4908451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nature of the development of changed properties of E. coli K-12 with increased resistance to levomycetin].
    Dugasheva LG; Levashev VS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):83-7. PubMed ID: 4593081
    [No Abstract]   [Full Text] [Related]  

  • 7. [Change in the biological properties of E. coli K-12 and S. typhimurium LT-2 during the development of resistance to levomycetin].
    Dugasheva LG
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Mar; 48(3):58-62. PubMed ID: 4932284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of chloramphenicol on experimental kidney infection caused by strains of E. coli with various sensitivity in vitro].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Cas Lek Cesk; 1969 Mar; 108(10):300-6. PubMed ID: 4887122
    [No Abstract]   [Full Text] [Related]  

  • 9. Integration of chloramphenicol-resistance genes of an R factor into various sites of an Escherichia coli chromosome.
    Iyobe S; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1970 Nov; 14(6):463-71. PubMed ID: 4922340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug resistance of enteropathogenic and normal Escherichia coli].
    Shal'man SL
    Antibiotiki; 1965 Dec; 10(12):1097-9. PubMed ID: 5337810
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloramphenicol resistance in clinical isolates of enterobacteria: characterization of chloramphenicol acetyltransferases.
    Rivera MJ; Cabello A; Gomez-Lus R
    J Chemother; 1989 Jul; 1(4 Suppl):309-10. PubMed ID: 16312415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conformation effects on the drug activity. 3. Synthesis and evaluation of the antibacterial activity of the treo-2-(dichloracetamide)-2-methyl-3-(p-nitrophenyl)butan-1,3-diol, analogue of 1,2-dimethylsubstituted chloramphenicol].
    Guarnieri M; Macchia B; Armani G
    Farmaco Sci; 1972 Oct; 27(10):882-92. PubMed ID: 4628642
    [No Abstract]   [Full Text] [Related]  

  • 13. Some properties of chloramphenicol acetyltransferase, with particular reference to the mechanism of inhibition by basic triphenylmethane dyes.
    Tanaka H; Izaki K; Takahashi H
    J Biochem; 1974 Nov; 76(5):1009-19. PubMed ID: 4616029
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydrophobic response of Escherichia coli exposed to subminimal inhibitory concentrations of ampicillin and chloramphenicol.
    Salami JO; Bassey E
    Afr J Med Med Sci; 1993 Dec; 22(4):53-6. PubMed ID: 7839930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of an Escherichia coli strain to chloramphenicol during therapy of experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1969 Sep; 108(39):1156-60. PubMed ID: 4897608
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of coresistance in the development of resistance to chloramphenicol in Escherichia coli isolated from sick cattle and pigs.
    Harada K; Asai T; Kojima A; Ishihara K; Takahashi T
    Am J Vet Res; 2006 Feb; 67(2):230-5. PubMed ID: 16454626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones.
    Kronvall G; Larsson M; Borén C; Kahlmeter G; Bartoloni A; Rossolini GM; Grape M; Kristiansson C; Karlsson I
    Int J Antimicrob Agents; 2005 Dec; 26(6):473-8. PubMed ID: 16280241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ricketsia prowazekii with hyperresistance to levomycetin and their properties].
    Zatulovskiĭ BG
    Antibiotiki; 1973 Feb; 18(2):153-6. PubMed ID: 4204628
    [No Abstract]   [Full Text] [Related]  

  • 19. Some effects of spermine on Escherichia coli.
    Mills J; Dubin DT
    Mol Pharmacol; 1966 Jul; 2(4):311-8. PubMed ID: 5338658
    [No Abstract]   [Full Text] [Related]  

  • 20. Two different types of conjugation-prone recipients for an FII plasmid in populations of an E. coli O26 strain.
    Coratza G; Molina AM; Musmanno RA; Marri L; Margollicci MA
    Microbiologica; 1984 Apr; 7(2):141-50. PubMed ID: 6379377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.